AwardTape · Defense awards · Medical · Health care services · W81XWH20C0137
W81XWH20C0137: $22.7M definitive contract to Scandinavian Biopharma Holding AB
Scandinavian Biopharma Holding AB holds a definitive contract from Defense Health Agency with $22.7M obligated since Oct 2023 and $44.2M obligated over its life, against a ceiling of $51.7M. Latest action Jun 5, 2026.
This award is for the delivery of a cgmp manufactured product of quantity and quality that IT is suitable and appropriate for use in pivotal clinical studies to demonstrate efficacy against etec in adults with the goal of fda licensure.
| PIID | W81XWH20C0137 |
|---|---|
| Type | definitive contract |
| Company | Scandinavian Biopharma Holding AB |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Medical · Health care services |
| PSC | Q517 PHARMACY SERVICES |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $22.7M |
| Total obligated (lifetime) | $44.2M |
| Ceiling (base and all options) | $51.7M |
| Base date | Sep 25, 2020 |
| Latest action | Jun 5, 2026 |
| End date | Sep 30, 2028 |
| Actions since Oct 2023 | 7 |
| Pricing | Fixed price level of effort |
| Competition | Not competed |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial